MiR-106b promotes cell proliferation via targeting RB in laryngeal carcinoma
2011

MiR-106b and its Role in Laryngeal Carcinoma

Sample size: 20 publication Evidence: moderate

Author Information

Author(s): Cai Kemin, Wang Yu, Bao Xueli

Primary Institution: Taizhou People's Hospital

Hypothesis

MiR-106b promotes cell proliferation in laryngeal carcinoma by targeting the tumor suppressor RB.

Conclusion

The study found that reducing miR-106b inhibits cell proliferation and induces cell cycle arrest in laryngeal carcinoma cells.

Supporting Evidence

  • Reduction of miR-106b induced cell cycle G0/G1 arrest.
  • RB was identified as a direct target of miR-106b.
  • High miR-106b expression was found in advanced stage laryngeal carcinoma tissues.

Takeaway

This study shows that a molecule called miR-106b helps cancer cells grow, and if we reduce it, the cancer cells stop growing.

Methodology

The study involved collecting laryngeal carcinoma tissues, cell culture, transfection, and various assays including MTT and luciferase reporter assays.

Limitations

The study was limited to a small sample size and focused only on laryngeal carcinoma.

Participant Demographics

The study included 20 patients with laryngeal carcinoma, with 10 at stages I and II and 10 at stages III and IV.

Statistical Information

P-Value

p<0.005

Statistical Significance

p<0.01

Digital Object Identifier (DOI)

10.1186/1756-9966-30-73

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication